Carregant...
Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model
Oxaliplatin (OXA)-based chemotherapy is widely used in the treatment of gastrointestinal tumors; however, it is associated with chemotherapy-associated liver injury. Whether OXA induces liver injury and aggravates the already existing hepatic oxidative stress, inflammation and fibrosis in non-alcoho...
Guardat en:
| Publicat a: | Int J Mol Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488186/ https://ncbi.nlm.nih.gov/pubmed/30942432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2019.4154 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|